Posted by
The higher price of new cancer drugs is rarely justified

The higher price of new cancer drugs is rarely justified

The higher price of new cancer drugs is rarely justified Most cancer drugs introduced since 2004 provide low added value compared to previously approved medications, but have much higher prices, according to a French study presented at the congress of the European Society for Medical Oncology (ESMO 2019) currently underway in Barcelona. «Most of the new […]